Tratamiento de hepatitis C en la insuficiencia renal crónica terminal en hemodiálisis con Interferón 2 b y ribavirina: A case report Treatment of hepatitis C in end-stage chronic renal failure in hemodialysis with Interferon 2 b and ribavirine

Tratamiento de hepatitis C en la insuficiencia renal crónica terminal en hemodiálisis con Interferón 2 b y ribavirina: A case report Treatment of hepatitis C in end-stage chronic renal failure in hemodialysis with Interferon 2 b and ribavirine

Se realizó la presentación clínica de un paciente de 32 años con antecedentes de salud hasta los 29 años de edad en que comienza a presentar una insuficiencia renal crónica terminal, se le aplicó tratamiento dialítico inmediatamente y 5 meses después se le diagnosticó una hepatitis C. Se decidió rea...

Full description

Bibliographic Details
Main Authors:	Yanet Parodis López, Alexis Pérez Rodríguez, Enrique Arus Soler, Francisco Gutiérrez, Orestes Benítez Llanes, Alexander Mármol Sóñora
Format:	Article
Language:	Spanish
Published:	Editorial Ciencias Médicas 2005-08-01
Series:	Revista Cubana de Medicina
Subjects:	Hemodiálisis hepatitis C interferón ribavirina Hemodialysis interferon ribavirine
Online Access:	http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232005000400012

Similar Items

Tratamento de pacientes com hepatite crônica pelo vírus C com interferon-alfa e ribavirina: a experiência da Secretaria de Saúde do Rio Grande do Sul Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil
by: Alexandro Vaesken Alves, et al.
Published: (2003-12-01)

Interferón alfa 2b recombinante más ribavirina en el tratamiento de la hepatitis crónica C Recombinant Interferon alfa-2b plus Ribavirin in treatment of chronic hepatitis C
by: Yoan Antonio Sánchez Rodríguez, et al.
Published: (2010-06-01)

Molde brônquico devido ao uso de interferon peguilado e ribavirina Bronchial casts attributed to the use of pegylated interferon and ribavirin
by: Eduardo Garcia, et al.
Published: (2009-07-01)

A taxa de resposta sustentada da hepatite C crônica ao tratamento com os diversos interferons-alfa e ribavirinas distribuídos pelo governo brasileiro é semelhante à da literatura mundial The sustained response rates for chronic hepatitis C patients undergoing therapy with the several interferons and ribavarins supplied by Brazilian’s Health Ministry is comparable to those reported in the literature
by: Rafael Nastás Acras, et al.
Published: (2004-03-01)

Interferon-ribavirin therapy for chronic hepatitis C: Efficacy in Saudi patients
by: Sandokji Abdulkareem, et al.
Published: (2003-01-01)

Interferon convencional versus interferon peguilado associados à ribavirina no tratamento de pacientes coinfectados pelo vírus da hepatite C (genótipo 1) e da imunodeficiência humana Alpha-interferon versus peg-interferon associated to ribavirin in the treatment of genotype 1 hepatitis C virus and human imunodeficiency virus coinfected patients
by: Paulo Roberto Lerias de Almeida, et al.
Published: (2009-06-01)

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Edmundo P.A. Lopes, et al.

Therapy with interferon-a plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Lopes Edmundo P.A., et al.
Published: (2003-01-01)

Celiac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C Doença celíaca após tratamento de hepatite C crônica com interferon peguilado e ribavirina
by: Elson V. Martins Jr., et al.
Published: (2004-06-01)

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
by: Liu Jun-Ying, et al.
Published: (2012-09-01)

A Comparison of Interferon-Alpha-2b Induction Therapy with Interferon-Alpha-2b Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
by: Bilgehan AYGEN, et al.
Published: (2004-09-01)

Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin.
by: Mansour Hassan, et al.
Published: (2020-01-01)

Daily interferon induction regimen using different manufactured interferons (alpha-2a or alpha-2b) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study Esquema de indução diário com interferon alfa 2-a ou alfa 2-b em combinação com ribavirina para tratamento da hepatite crônica C: estudo prospectivo randomizado
by: Eduardo Lorens Braga, et al.
Published: (2006-12-01)

Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
by: Aline Gonzalez Vigani, et al.

Ocular manifestations in Egyptian children with chronic hepatitis C treated with pegylated interferon and ribavirin
by: Dalia H.A.R Khalil, et al.
Published: (2016-01-01)

Efficacy of triple therapy with interferon alpha-2b, ribavirin and amantadine in the treatment of naïve patients with chronic hepatitis C
by: Hamid Kalantari, et al.
Published: (2007-08-01)

Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C Oscilaciones de la ferritina sérica asociadas al tratamiento antiviral en la hepatitis crónica por virus C
by: J. M. Ladero, et al.
Published: (2009-01-01)

Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
by: Luis Jesuino de Oliveira Andrade, et al.

Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review
by: Luis Jesuíno de Oliveira Andrade, et al.

Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
by: Mario Espinosa, et al.
Published: (2015-05-01)

Maintenance of T1 response as induced during PEG-IFNalpha plus ribavirin therapy controls viral replication in genotype-1 patients with chronic hepatitis C La respuesta inmune T1 inducida durante el tratamiento con PEG-IFNα mαs ribavirina controla la replicaciσn viral en pacientes con hepatitis crónica C
by: M. Trapero, et al.
Published: (2005-07-01)

Evaluation of combination therapy with Interferon and Ribavirin in patients with chronic hepatitis C : a genotype based study
by: Y. Bafandeh, et al.
Published: (2007-01-01)

ORIGINAL PAPER <br>Combined interferon-alpha-2b and ribavirin therapy in patients with recurring chronic hepatitis C (genotype 1) following liver transplantation in Hungary
by: Gabriella Lengyel, et al.
Published: (2005-04-01)

Combined pegylated interferon and ribavirin for the management of chronic hepatitis C in a prison setting
by: Sergio Sabbatani, et al.

The interleukin 28B gene polymorphism, rs8099917, in patients with chronic hepatitis C and response to the treatment with pegylated interferon and ribavirin
by: Hamid Kalantari, et al.
Published: (2019-01-01)

Gender influence on treatment of chronic hepatitis C genotype 1 Influência do gênero no tratamento da hepatite C crônica genótipo 1
by: Janaína Luz Narciso-Schiavon, et al.
Published: (2010-06-01)

Histological response study of chronic viral hepatitis C patients treated with interferon alone or combined with ribavirin
by: Kleber Prado, et al.

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
by: Nishikawa Hiroki, et al.
Published: (2012-03-01)

Lymph node enlargement during combination therapy for chronic hepatitis C with pegylated interferon alpha and ribavirin: harmless reaction or harmful disease?
by: M Wilhelmi, et al.
Published: (2006-01-01)

Treatment with pegylated interferon alpha 2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin Tratamiento con PEG interferón alfa 2b y ribavirina en enfermos previamente tratados con interferón estándar en monoterapia o combinado con ribavirina
by: F. Carnicer, et al.
Published: (2005-05-01)

El interferón en el tratamiento de la hepatitis C crónica Inmunobiología básica e inmunopatología del hígado Interferon treatment of chronic hepatitis C: Basic immunobiology and immunopathology of the liver
by: J.S. Mazana
Published: (2013-06-01)

An open, non-controlled clinical study to assess the efficacy and safety of the recombinant human alpha 2b pegylated interferon PEG-Heberon® plus ribavirin for the treatment of chronic hepatitis C virus infection in Cuban patients
by: Marlen I Castellanos-Fernández, et al.

Antiviral/immunomodulatory combination therapy: Pegylated interferon alpha 2a and ribavirin in patients with chronic hepatitis C virus infection
by: Delić Dragan, et al.
Published: (2012-01-01)

Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy
by: Shin-Yu Lu, et al.
Published: (2009-12-01)

Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferon-alpha and ribavirin: A prospective study
by: Ružić Maja, et al.
Published: (2017-01-01)

PEG-INTERFERON ALPHA-2A AND LOW-DOSE RIBAVIRIN FOR TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITH SICKLE CELL ANEMIA IN SAUDI ARABIA.
by: Adnan Agha
Published: (2014-08-01)

Response to treatment with interferon-alpha and ribavirin in patients with chronic Hepatitis C virus genotypes 2 and 3 depends on the degree of hepatic fibrosis
by: Edison Roberto Parise, et al.

Effect of IL-28 B Polymorphisms on Early Virological Response (EVR) in Chronic Hepatitis C Patients Treated with Interferon and Ribavirin
by: Madeeha Nazar
Published: (2016-09-01)

Pityriasis Rosea Associated with Pegylated Interferon Alfa and Ribavirin Treatment in a Patient with Chronic Hepatitis C
by: Rahmet Güner, et al.
Published: (2013-06-01)

Treatment issues surrounding hepatitis C in renal transplantation: A review
by: Edward Kim, et al.
Published: (2011-01-01)